Navigation Links
LifeNet Health and Soluble Systems Announce Partnership to Launch TheraSkin(TM)
Date:3/5/2010

room environment pursuant to FDA regulations in Hampton, Virginia. Corporate offices are located in Newport News, Virginia. For additional information about Soluble Systems, TheraGauze™ and TheraSkin™, visit www.solublesystems.com.

About SWAI and LifeNet Health: SWAI, the Skin and Wound Allograft Institute, is a wholly owned non-profit subsidiary of LifeNet Health.  It was formed in 2008 to provide high quality bio-implants for patients with acute burns, traumatic injuries and chronic wounds.  The Institute continually strives to be a leader in bio-implant research and discover new therapies to improve the lives of patients that have suffered a debilitating burn, traumatic injury or chronic non-healing wound. LifeNet Health, a non-profit global leader in regenerative medicine, is the world's largest provider of bio-implants and organs for transplantation whose mission is saving lives and restoring health by advancing the field of tissue engineering.  For additional information about SWAI and LifeNet Health, visit www.swai.org and

SOURCE LifeNet Health
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. LifeNet Health and IMS Announce Partnership
2. LifeNet Health and LOPA Announce a Partnership
3. LifeNet Health Saves 303 Lives and Restores Health to 265,967 Patients in 2007
4. LifeNet Health(R) Unveils New Biomedical Spine Implant
5. ETEX and LifeNet Health, Inc. Enter Agreement
6. LifeNet Health Chief Scientific Officer Wins Award
7. LifeNet Health Introduces New Sports Medicine Bio-Implants
8. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
9. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
10. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
11. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Xeno Diagnostics has again received an ... COLA inspection. Xeno has met all criteria for ... organization. Accreditation is earned only by laboratories that ... demonstrate continued accuracy in the performance of proficiency ... , While the Laboratory Excellence award ...
(Date:12/17/2014)... Audacity, a leading California-based health and science ... Huntsworth Health Group, is proud to announce the addition ... role, Gonzales will serve as Senior Vice President of ... welcome a talent of Jamie’s caliber to the Audacity ... is a proven healthcare innovation leader and brand management ...
(Date:12/17/2014)... Dec. 17, 2014  United Therapeutics Corporation (NASDAQ: ... as well as changes to Martine Rothblatt , ... United Therapeutics announced the promotion of ... Executive Officer and David Zaccardelli , Pharm.D. to ... with these promotions, Dr. Rothblatt,s title will change from ...
(Date:12/17/2014)... FRANCISCO, Calif. , Dec. 17, 2014 /PRNewswire/ ... of a Phase 2 study evaluating the investigational ... treatment of patients with severe, chronic itch who ... standard of care, including topical steroids and antihistamines. ... percent change in Visual Analog Scale (VAS) itch ...
Breaking Biology Technology:Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 3United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
... everything from explosives to tainted milk, materials for use ... by a University of Houston (UH) chemist and his ... "There are many dangerous substances, pollutants and ... Advincula, a highly cited materials scientist at UH. "Our ...
... February 7, 2011 -- A low cost, nanometer-sized drug ... burns, has been developed by a group of scientists from ... in the U.S. and Japan. Diabetes is a ... the world,s population. Poor blood circulation arising from diabetes often ...
... Feb. 16, 2011 / PRNewswire/ -- Sigma-Aldrich® ... following executive leadership appointments intended to more closely ... Frank Wicks, President Research, will assume ... including those in Research Essentials, Research Specialties and ...
Cached Biology Technology:Sensors to detect explosives, monitor food being developed at UH 2Sensors to detect explosives, monitor food being developed at UH 3Sigma-Aldrich Announces Organizational Changes 2Sigma-Aldrich Announces Organizational Changes 3
(Date:12/11/2014)... 2014  That blood pressure plays a role in human ... the medical term for high blood pressure – was first ... inflatable cuff that,s used in measuring blood pressure was invented ... new about hypertension, its triggers and its effects. In fact, ... and the best ways to treat it. For ...
(Date:12/10/2014)... YORK , Dec. 8, 2014 You,ve been ... banking account but can,t remember your password, site key or ... Who was your first grade teacher? Today, ... the app that will finally put an end ... – 1U TM . 1U leverages a user,s ...
(Date:12/10/2014)... , Dec. 9, 2014  Wake Forest Baptist Medical Center ... for its School of Medicine. Funding for this $50 ... campaign that will be publicly launched next summer. ... in the former 60 series R.J. Reynolds Tobacco Company ... Construction will begin immediately with plans to be ready ...
Breaking Biology News(10 mins):Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
... plant geneticists and crop scientists has pioneered an economical ... boost levels of provitamin A, the precursors that are ... help to enhance the nutritional status of millions of ... is described this week in the journal Science. ...
... Genetic Alliance, an organization devoted to accelerating the translation ... healthcare, has named Genetic Testing as its official journal. Genetic ... Inc. ... Genetic Testing, says Sharon Terry, President and CEO of Genetic ...
... Australias extinct marsupial lion (Thylacoleo carnifex) would have made ... the two big hyper-carnivores ever squared off in a ... New research published in the Journal of Zoology ... type teeth to scissor through hide and flesh to ...
Cached Biology News:Team finds an economical way to boost the vitamin A content of maize 2Team finds an economical way to boost the vitamin A content of maize 3Genetic Alliance names Genetic Testing as its official journal 2Marsupial lion tops African lion in fight to death 2
... multi-purpose, high gel-strength agarose suitable for a ... conventional constant field to Pulsed Field Gel ... strength and exclusion limits, Multi ABgarose can ... running times. This in turn means reduced ...
Mouse monoclonal [1.F.1] to Yersinia pestis F1 antigen ( Abpromise for all tested applications). Antigen: Purified F1 antigen of Y. pestis vaccine strain EB....
Rabbit polyclonal to L Kynurenine ( Abpromise for all tested applications). Antigen: Synthetic peptide L Kynurenine conjugated to a protein carrier. Entrez Gene ID: 8942 Swiss Protein ID...
Rabbit polyclonal to P5 ( Abpromise for all tested applications). entrezGeneID: 10954 SwissProtID: Q14554...
Biology Products: